LobbyingAmbassadors Group lobbying by quarter
Ambassadors Group's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Ambassadors Group
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $60K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $20K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $20K | 1 |
| Q2 2024 | $20K | 1 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $20K | 1 |
| Q4 2025 | $20K | 1 |
| Q1 2026 | $20K | 1 |
| Q2 2026 | $20K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$150K · 15 reports
- Medicare and Medicaid$150K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)15 reports
- Health & Human Services, Dept of (HHS)15 reports
- Health Resources & Services Administration (HRSA)15 reports
- HOUSE OF REPRESENTATIVES10 reports
- SENATE10 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmbassadors Group | $300K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/10for Q2 | In-house | $20K |
| 04/10for Q1 | In-house | $20K |
| 01/21for Q4 2025 | In-house | $20K |
| 25/11/20for Q3 2025 | In-house | $20K |
| 25/07/11for Q2 2025 | In-house | $20K |
| 25/04/11for Q1 2025 | In-house | $20K |
| 25/02/02for Q4 2024 | In-house | $20K |
| 24/11/05for Q3 2024 | In-house | $20K |
| 24/07/10for Q2 2024 | In-house | $20K |
| 24/04/11for Q1 2024 | In-house | $20K |
| 24/01/10for Q4 2023 | In-house | $20K |
| 23/11/20for Q3 2023 | In-house | $20K |
| 23/08/04for Q2 2023 | In-house | $20K |
| 23/04/11for Q1 2023 | In-house | $20K |
| 23/01/10for Q4 2022 | In-house | $20K |